Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole sodium injection for peptic ulcer bleeding
CTR20133004Phase 2Active
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ilaprazole in Peptic ulcer disease (PUD), sponsored by Livzon Pharmaceutical Group Inc.. Started Aug 2014; status: active.
02
Drugs
ilaprazole
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20133004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20133004.